Akeso Inc

9926.HK

$6.12

Closing

▼-3.13%

1D

▲3.34%

YTD

Market cap

$5.30B

52 week high

$7.03

52 week low

$3.87

Volume

2,559,217

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$5.30B

Analysts' Rating

BUY

Price Target (Mean)

0.00

Total Analysts

0

P/E

18.28

Operating Margin

0.00%

Beta

0.75

Revenue Growth (Annual)

-

52 week high

$7.03

52 week low

$3.87

Div. Yield

%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Akeso Inc is an investment holding company mainly engaged in the research and development of biological products. The Company is dedicated to addressing global unmet medical needs in oncology, immunology and other therapeutic areas. The Company’s main products include AK104, AK105, AK112 and AK109. The Company conducts its businesses within the China market and to overseas markets.